MedTrace Logo

RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine

NCT02122744 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-08-18

No results posted yet for this study

Summary

Evaluation of inhibiting rTMS QP over the visual cortex for the prevention of chronic migraine. The aim of the study is to confirm that inhibiting rTMS QP is capable to decrease the frequency of migraine and if its effect is stronger than placebo effect.

Conditions

  • Chronic Migraine

Interventions

DEVICE

Super Rapid Magstim Stimulator

The repetitive transcranial magnetic stimulation (rTMS) is able to modify cortical excitability and reactivity. 1Hz rTMS inhibits the cortex, 10Hz excites it. In particular, a new paradigm of rTMS, the rTMS quadri pulse has a more lasting and effective activity. The side effects are rare and transient: migraine,contractions of the muscles of the neck due to muscle stimulation by the electromagnetic field of the coil.

DEVICE

Super Rapid Magstim Stimulator (sham)

coil perpendicular to the scalp

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Jean Schoenen, HP · University of Liege

  • Delphine Magis, MD,PhD · University of Liege

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-04-30
Completion
2014-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02122744 on ClinicalTrials.gov